RFK Jr. is canceling mRNA vaccine development. Can I still get a COVID vaccine?
In a video posted on X Aug. 5, Kennedy said the decision will impact 22 projects worth nearly $500 million at the Biomedical Advanced Research and Development Authority, which helps companies develop medical supplies to address public health threats.
Messenger RNA, or mRNA, is used in the two most common COVID-19 vaccines licensed in the U.S. Kennedy's announcement has raised questions about these vaccines, how mRNA works and what this decision means for future research.
"This technology played a vital role in our pandemic response and continues to show promise for treating serious diseases," said Jeff Coller, Bloomberg Distinguished Professor of RNA biology and therapeutics at Johns Hopkins University. "As other countries advance these proven, safe and effective therapies, American patients may increasingly depend on foreign innovation for breakthrough treatments."
How do mRNA vaccines work?
The COVID-19 vaccine works by instructing the body's immune system to recognize the virus and creating fighting antibodies to attack it.
Messenger RNA, or mRNA, is a code that tells the body's cells to produce just a piece of the virus, the protein on the surface. The code is protected by a lipid coating, like a fat bubble.
mRNA vaccines: RFK Jr. to wind down $500M vaccine development
Once injected into the body, the vaccine releases the mRNA to program the cell to produce the spike proteins like those on the surface of SARS-CoV-2, the COVID-19 virus. Our immune system recognizes those vaccine-created spike proteins as invaders and creates antibodies to block future attacks from the virus.
Messenger RNA vaccines contain only a fraction of the virus, so unlike some vaccines, they can't give people the disease they're trying to prevent or trigger allergies to eggs or other traditional vaccine ingredients.
Should I expect a COVID vaccine this fall?
It's unclear whether patients should be expecting COVID-19 vaccines this fall, said Dr. Beth Oller, a family physician in Stockton, Kansas, and clinical instructor at the University of Kansas School of Medicine-Wichita.
In June, Kennedy fired all members of the Advisory Committee on Immunization Practices, a key vaccine panel that makes recommendations for COVID-19 and other vaccines, and appointed eight new members. During its first meeting, the committee did not make any recommendations for the fall and isn't expected to reconvene until "September/October," according to the Centers for Disease Control and Prevention website.
Kennedy said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process.
Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection.
The American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP), among other organizations, issued statements condemning the change, with the ACOG saying it was "...concerned about and extremely disappointed by the announcement that HHS will no longer recommend COVID-19 vaccination during pregnancy."
Will insurance cover my COVID shot?
Many consumers are worried about possible cuts to health insurers' coverage of vaccines, a recent poll said.
A KFF poll published Aug. 1 found 40% of adults said they will "definitely" or "probably" get a COVID-19 vaccine shot. Of those who intend to get vaccinated, 62% said they are worried insurance won't cover the cost of the vaccine.
Groups representing commercial health insurance companies said they still plan to cover vaccines recommended by the CDC and ACIP, the vaccine advisory panel.
"Health plans continue to follow federal requirements related to coverage of ACIP-recommended vaccines and will continue to support broad access to critical preventive services, including immunizations," said Tina Stow, spokesperson for AHIP, which represents health insurance companies.
COVID: As new variant spreads, what's the latest vaccine guidance?
The CDC currently recommends shared decision-making between parents and doctors for immunizing children with the COVID-19 vaccine. It also recommends vaccines for people who are moderately or severely immune compromised.
Large employers that provide health insurance benefits for workers and their families will likely continue to cover Food and Drug Administration-approved vaccines, said James Gelfand, president and CEO of the ERISA Industry Committee.
In some cases, employer vaccine coverage might follow FDA approvals rather than narrower ACIP recommendations.Contributing: Mary Walrath-Holdridge
Adrianna Rodriguez can be reached at adrodriguez@usatoday.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Chicago Tribune
20 minutes ago
- Chicago Tribune
Robert F. Kennedy Jr.'s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement
WASHINGTON — Health Secretary Robert F. Kennedy Jr. is vowing to 'fix' the federal program for compensating Americans injured by vaccines, opening the door to sweeping changes for a system long targeted by anti-vaccine activists. Health experts and lawyers say updates are needed to help clear a backlog of cases in the Vaccine Injury Compensation Program, created by Congress in 1986 as a no-fault payment system for presumed vaccine injuries. But they also worry Kennedy's changes will reflect his history as a leader in the anti-vaccine movement, which has alternately called for abolishing the program or expanding it to cover unproven injuries and illnesses that aren't connected to vaccines. Kennedy and other critics believe the program is 'too miserly in what it considers to be a vaccine injury,' said Jason Schwartz, a public health expert at Yale University. 'That's created great concern that he could expand what's included.' Anti-vaccine groups have long suggested a link between vaccines and autism, despite scientific consensus that childhood vaccines don't cause the condition. Adding autism to the list of injuries covered by the plan 'would dramatically increase the number of compensable cases, potentially bankrupting it,' Schwartz said. Signed into law under President Ronald Reagan, the compensation program is designed to provide quick, efficient compensation to Americans who report known injuries associated with vaccines, such as rare allergic reactions. At the time of its creation, a number of vaccine-makers were exiting the business due to risks of class action lawsuits. In a recent social media post, Kennedy called the program 'broken' and accused federal lawyers and adjudicators who run it of 'inefficiency, favoritism and outright corruption.' Kennedy didn't specify the changes he's seeking. But some of the people he's enlisted to help have a history of bringing vaccine injury cases. In June, the Department of Health and Human Services awarded a $150,000 contract to an Arizona law firm for 'expertise' in the program. The firm's Andrew Downing, an attorney specializing in vaccine injury cases, was listed in the HHS staff directory for a time. 'We just brought a guy in this week who is going to be revolutionizing the Vaccine Injury Compensation Program,' Kennedy told Tucker Carlson shortly after the award. Revamping the program would be the latest in a string of decisions that have upended U.S. vaccine policy, including this week's cancellation of research funding for vaccines using mRNA technology. Downing has had a leading role in lawsuits against Merck alleging injuries from its HPV vaccine, Gardasil, including a rare movement disorder. In a podcast last year for people with the condition, Downing lamented that the injury compensation program 'has taken a hard line' against such cases, leading lawyers to file injury lawsuits in civil court. Approximately 70% of the Gardasil cases against Merck started as claims filed by Downing in the federal injury program, according to court records. A judge dismissed more than 120 of those cases, citing 'a paucity of evidence' that Gardasil caused patients' problems. A spokesman for Kennedy declined to comment on Downing's hiring. Kennedy himself has been involved in the Gardasil litigation, as both an attorney and consultant. Before joining the government, Kennedy received payments for referring potential Gardasil clients to Wisner Baum, one of the law firms suing Merck. Following questions about the agreement during his confirmation hearings, Kennedy agreed to give up his stake in the deal and transfer any future fees to 'a nondependent, adult son,' according to his financial disclosures. One of Kennedy's sons is an attorney at Wisner Baum. Experts who study vaccine compensation say real changes are needed to modernize the 40-year-old program. The cap on compensation remains $250,000 for injury or death, the same as in 1986. Similarly, the program still has eight adjudicators, known as special masters, to review all cases before the government. On average, the process takes two to three years. The fund has paid out $5.4 billion, compensating about 40% of all people who filed claims. The U.S. has an 'ethical obligation' to promptly pay those harmed by government-recommended vaccines, says Dorit Reiss, a professor at the University of California Hastings College of the Law. 'Plus, I think it increases trust in the vaccination program if you have quick, generous compensation,' Reiss said. As health secretary, Kennedy has broad powers to reshape the program. One approach could be adding new diseases and illnesses to the government table of payable injuries. In the early 2000s, the program ruled against more than 5,000 claims from families who said vaccines led to their children's autism, citing hundreds of scientific studies discrediting the link. Critics of Kennedy say he could claim that he has new evidence of harm — perhaps from a large autism study he's commissioned — and add the condition to the program. In response, the federal government might have to increase taxes on vaccines to replenish the compensation fund, which would make the shots more expensive and less accessible. 'Then you will start to watch the vaccine program infrastructure in this country disintegrate until someone steps in,' Dr. Paul Offit, a vaccine researcher at Children's Hospital of Philadelphia who has clashed with Kennedy for years. A recent Senate hearing titled 'Voice of the Vaccine Injured' appeared to make the case for expanding the program. Witnesses included two representatives from Children's Health Defense, the nonprofit group that Kennedy previously chaired and has repeatedly sued the government over vaccines. The group's chief science officer, Brian Hooker, told lawmakers he tried unsuccessfully for 16 years trying to get compensation for his son's autism, which he attributes to the measles-mumps-rubella vaccine. Another approach would involve removing certain vaccines from the program, making it easier to bring lawsuits against vaccine-makers. Under current law, people claiming injuries from vaccines covered by the program must first pursue a compensation claim before they can sue. In cases where the science doesn't support a connection to vaccines, lawyers might be more successful before a jury. 'Jury trials take advantage of the fact that most jurors don't know anything about science or medicine,' Offit said. 'They are not going to be as easily moved by the data.' Still, attorneys who bring cases before the compensation program say the process has become more burdensome and adversarial over the years. Even small changes could improve things. For instance, the statute of limitations for claims could be extended beyond the current three years, which lawyers say cuts off many potential clients. 'I'm hoping there will be changes put in place that make the program easier for petitioners to navigate' said Leah Durant, a vaccine injury attorney.
Los Angeles Times
20 minutes ago
- Los Angeles Times
Trump moves to shut down NASA missions that measure carbon dioxide and plant health
The Trump administration is moving to shut down two NASA missions that monitor a potent greenhouse gas and plant health, potentially shutting off an important source of data for scientists, policymakers and farmers. President Trump's budget request for fiscal year 2026 includes no money for the Orbiting Carbon Observatories, which can precisely show where carbon dioxide is being emitted and absorbed and how well crops are growing. NASA said in an emailed statement Wednesday that the missions were 'beyond their prime mission' and being terminated 'to align with the President's agenda and budget priorities.' But the missions — a free-flying satellite launched in 2014 and an instrument attached to the International Space Station in 2019 that include technology used in the Hubble Space Telescope — still are more sensitive and accurate than any other systems in the world, operating or planned, and a 'national asset' that should be saved, said David Crisp, a retired NASA scientist who led their development. They helped scientists discover, for example, that the Amazon rain forest emits more carbon dioxide than it absorbs, while boreal forests in Canada, Russia and places where permafrost is melting absorb more than they emit, Crisp said. They also can detect the 'glow' of photosynthesis in plants, which helps monitor drought and predict food shortages that can lead to civil unrest and famine, he said. 'This is really critical,' Crisp said. 'We're learning so much about this rapidly changing planet.' The decision to end the missions is 'extremely shortsighted,' said Jonathan Overpeck, a climate scientist at the University of Michigan. 'The observations provided by these satellites ... [are] critical for managing growing climate change impacts around the planet, including in the U.S.,' he said. Crisp and others hope Congress will vote to preserve funding for the missions, which are funded through the fiscal year that ends Sept. 30. A bill in the House closely aligns with the president's request and would eliminate the missions, while a Senate version preserves them. But with Congress in recess, it is unclear whether a budget will be adopted before the new fiscal year begins Oct. 1. If it doesn't, Congress could adopt a resolution to continue current funding until a budget is passed, though some lawmakers fear the Trump administration could try to delay or withhold that money. Congressional Democrats warned acting NASA Administrator Sean Duffy last month that it would be illegal to terminate missions or impound funds already appropriated by Congress. Experts said the administration's move to eliminate funding aligns with other actions to cut or bury climate science. 'The principle seems to be that if we stop measuring climate change it will just disappear from the American consciousness,' said University of Pennsylvania climate scientist Michael Mann. Crisp and others also are trying to put together a coalition of outside partners — including from Japan and Europe — that could fund and operate the instrument attached to the space station. NASA said it will accept outside proposals through Aug. 29. The free-flying satellite, though, is at risk of being brought down, meaning it would burn up in the atmosphere. National Public Radio first reported that NASA employees were making plans to end the missions. Crisp said advocates are hoping NASA also allows outside control of that satellite, which covers more of the globe, but there are legal hurdles to overcome because it would mean giving control of a U.S. satellite to a group that could include foreign partners. 'We're going out to billionaires. We're going out to foundations,' Crisp said. 'But ... it's a really, really bad idea to try and push it off onto private industry or private individuals or private donors. It just doesn't make sense.' Webber writes for the Associated Press.
Fox News
24 minutes ago
- Fox News
Republican senator claims RFK Jr. mRNA vaccine decision undermines Trump agenda
Sen. Bill Cassidy, R-La., has condemned the Department of Health and Human Services' move to shift funding away from mRNA vaccine development, claiming it undermines President Donald Trump's agenda to make the nation healthy again. "We reviewed the science, listened to the experts, and acted," Department of Health and Human Services Sec. Robert F. Kennedy Jr. said, according to an HHS press release. "BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." Cassidy registered his objection to the move. "It is unfortunate that the Secretary just canceled a half a billion worth of work, wasting the money which is already invested. He has also conceded to China an important technology needed to combat cancer and infectious disease. President Trump wants to Make America Healthy Again and Make America Great Again. This works against both of President Trump's goals," the lawmaker said in a post on X. The HHS stated, "While some final-stage contracts (e.g., Arcturus and Amplitude) will be allowed to run their course to preserve prior taxpayer investment, no new mRNA-based projects will be initiated. HHS has also instructed its partner, Global Health Investment Corporation (GHIC), which manages BARDA Ventures, to cease all mRNA-based equity investments. In total, this affects 22 projects worth nearly $500 million. Other uses of mRNA technology within the department are not impacted by this announcement." Fox News Digital reached out to Cassidy's office to request comment from the senator on Thursday, but did not receive a response by the time of publication. Cassidy, who has served in the upper chamber since 2015, is aiming to get re-elected in 2026, though the incumbent faces competition from other Republicans who have also launched bids for the Senate seat. In February 2021, Cassidy voted to convict Trump after the House impeachment in the wake of the January 6 episode at the U.S. Capitol. That Senate vote, which occurred after Trump had already left office, ultimately fell short of the threshold necessary to convict.
